Terns Pharmaceuticals Inc (TERN)
5.79
+0.08
(+1.40%)
USD |
NASDAQ |
Nov 22, 16:00
5.79
0.00 (0.00%)
After-Hours: 18:31
Terns Pharmaceuticals Price to Book Value: 1.349 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.331 |
| November 20, 2024 | 1.305 |
| November 19, 2024 | 1.377 |
| November 18, 2024 | 1.328 |
| November 15, 2024 | 1.438 |
| November 14, 2024 | 1.526 |
| November 13, 2024 | 1.580 |
| November 12, 2024 | 1.671 |
| November 11, 2024 | 1.738 |
| November 08, 2024 | 1.701 |
| November 07, 2024 | 1.645 |
| November 06, 2024 | 1.687 |
| November 05, 2024 | 1.670 |
| November 04, 2024 | 1.654 |
| November 01, 2024 | 1.617 |
| October 31, 2024 | 1.598 |
| October 30, 2024 | 1.605 |
| October 29, 2024 | 1.603 |
| October 28, 2024 | 1.517 |
| October 25, 2024 | 1.554 |
| October 24, 2024 | 1.573 |
| October 23, 2024 | 1.629 |
| October 22, 2024 | 1.747 |
| October 21, 2024 | 1.687 |
| October 18, 2024 | 1.726 |
| Date | Value |
|---|---|
| October 17, 2024 | 1.747 |
| October 16, 2024 | 1.782 |
| October 15, 2024 | 1.771 |
| October 14, 2024 | 1.775 |
| October 11, 2024 | 1.787 |
| October 10, 2024 | 1.725 |
| October 09, 2024 | 1.836 |
| October 08, 2024 | 1.820 |
| October 07, 2024 | 1.829 |
| October 04, 2024 | 1.927 |
| October 03, 2024 | 1.910 |
| October 02, 2024 | 1.910 |
| October 01, 2024 | 1.887 |
| September 30, 2024 | 1.943 |
| September 27, 2024 | 3.301 |
| September 26, 2024 | 3.417 |
| September 25, 2024 | 3.572 |
| September 24, 2024 | 3.711 |
| September 23, 2024 | 3.757 |
| September 20, 2024 | 3.869 |
| September 19, 2024 | 3.877 |
| September 18, 2024 | 3.942 |
| September 17, 2024 | 3.718 |
| September 16, 2024 | 3.633 |
| September 13, 2024 | 3.458 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.255
Minimum
May 11 2022
3.942
Maximum
Sep 18 2024
1.520
Average
1.516
Median
Price to Book Value Benchmarks
| Eli Lilly and Co | 49.85 |
| Viking Therapeutics Inc | 6.433 |
| Biomarin Pharmaceutical Inc | 2.262 |
| Elite Pharmaceuticals Inc | 13.94 |
| Verrica Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 5.79 |
| Earnings Yield | -20.38% |
| Market Cap | 491.80M |